EMEA-001467-PIP01-13 - paediatric investigation plan

Perindopril erbumine

Amlodipine besilate

Key facts

• Active Substance:
  • Perindopril erbumine
  • Amlodipine besilate
• Decision number:
  P/0230/2013
• PIP number:
  EMEA-001467-PIP01-13
• Pharmaceutical form(s):
  Tablet
• Condition(s) / indication(s):
  Treatment of hypertension
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  23/09/2013

Decision

P/0230/2013: EMA decision of 23 September 2013 on the granting of a product specific waiver for perindopril (erbumine) / amlodipin (besylate), (EMEA-001467-PIP01-13)

AdoptedReference Number: EMA/561630/2013